Effect of Different Does of Simvastatin in Reducing Serum Lipid
Min Wang
Abstract
Min Wang
Abstract
Objective:Comparing the effect of different doses of simvastatin in lowering the serum lipid. Methods:79 patients were randomized into group A and group B, and were given simvastatin 10 mg·d -1 (group A) and 20 mg·d -1 (group B), respectively for a total of 8 weeks. Results:Comparing with baseline, in group A, TC, TG, LDL-C were decreased by 23.4%, 20.0% and 30.7%, respectively (P0.01); HDL-C was increased by 17.5%. The content of serum TC, TG and LDL-C was decreased to the normal range in 12.8%, 28.2% and 15.4% of the patients in group A. For the group B, TC, TG, LDL-C were decreased by 32.7%, 22.8% and 42.8%, respectively (P0.01); HDL-C was increased by 13.7%. The content of serum TC, TG and LDL-C was decreased to the normal range in 65.0%, 57.5% and 65.0% of the group B patients. Conclusion:Oral intake of 20 mg of simvastatin once a day can effectively reduce the serum lipid. The patients can well tolerate and no obvious side effect was observed in our study.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:Comparing the effect of different doses of simvastatin in lowering the serum lipid. Methods:79 patients were randomized into group A and group B, and were given simvastatin 10 mg·d -1 (group A) and 20 mg·d -1 (group B), respectively for a total of 8 weeks. Results:Comparing with baseline, in group A, TC, TG, LDL-C were decreased by 23.4%, 20.0% and 30.7%, respectively (P0.01); HDL-C was increased by 17.5%. The content of serum TC, TG and LDL-C was decreased to the normal range in 12.8%, 28.2% and 15.4% of the patients in group A. For the group B, TC, TG, LDL-C were decreased by 32.7%, 22.8% and 42.8%, respectively (P0.01); HDL-C was increased by 13.7%. The content of serum TC, TG and LDL-C was decreased to the normal range in 65.0%, 57.5% and 65.0% of the group B patients. Conclusion:Oral intake of 20 mg of simvastatin once a day can effectively reduce the serum lipid. The patients can well tolerate and no obvious side effect was observed in our study.
Key concepts: Simvastatin, Internal medicine, Group B, Chemistry, Blood lipids, Group A, Endocrinology, Medicine